Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in Houston, Texas and Dynavax technologies based in Emeryville, California. From Wikipedia
Genome sequencing has been expanded to identify LF.7, XFG, JN.1.16, NB.1.8.1 sub-variants to guide vaccine strategy
